Weijing Cai - Publications

Affiliations: 
2012- University of Florida, Gainesville, Gainesville, FL, United States 

11/121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cai W, Ratnayake R, Wang M, Chen QY, Raisch KP, Dang LH, Law BK, Luesch H. Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasm. Current Research in Pharmacology and Drug Discovery. 2: 100053. PMID 34909679 DOI: 10.1016/j.crphar.2021.100053  0.735
2018 Cai W, Ratnayake R, Gerber MH, Chen QY, Yu Y, Derendorf H, Trevino JG, Luesch H. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Investigational New Drugs. PMID 30073464 DOI: 10.1007/S10637-018-0647-0  0.736
2018 Cai W, Matthew S, Chen QY, Paul VJ, Luesch H. Discovery of new A- and B-type laxaphycins with synergistic anticancer activity. Bioorganic & Medicinal Chemistry. PMID 29606488 DOI: 10.1016/J.Bmc.2018.03.022  0.731
2017 Cai W, Chen QY, Dang LH, Luesch H. Correction to "Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors". Acs Medicinal Chemistry Letters. 8: 1342. PMID 29266134 DOI: 10.1021/Acsmedchemlett.7B00498  0.749
2017 Cai W, Salvador-Reyes LA, Zhang W, Chen QY, Matthew S, Ratnayake R, Seo SJ, Dolles S, Gibson DJ, Paul VJ, Luesch H. Apratyramide, a Marine-Derived Peptidic Stimulator of VEGF-A and Other Growth Factors with Potential Application in Wound Healing. Acs Chemical Biology. PMID 29205032 DOI: 10.1021/Acschembio.7B00827  0.7
2017 Cai W, Chen QY, Dang LH, Luesch H. Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors. Acs Medicinal Chemistry Letters. 8: 1007-1012. PMID 29057042 DOI: 10.1021/Acsmedchemlett.7B00192  0.762
2016 Wu P, Cai W, Chen QY, Xu S, Yin R, Li Y, Zhang W, Luesch H. Total Synthesis and Biological Evaluation of Apratoxin E and Its C30 Epimer: Configurational Reassignment of the Natural Product. Organic Letters. PMID 27723359 DOI: 10.1021/Acs.Orglett.6B02780  0.695
2016 Cai W, Matthews JH, Paul VJ, Luesch H. Pitiamides A and B, Multifunctional Fatty Acid Amides from Marine Cyanobacteria. Planta Medica. PMID 27135625 DOI: 10.1055/S-0042-105157  0.7
2015 Cai W, Salvador-Reyes L, Zhang W, Matthew S, Ratnayake R, Paul V, Dang L, Luesch H. Discovery, synthesis, and biological evaluation of apratyramide, a marine-derived transcriptional stimulator of VEGF-A Planta Medica. 81. DOI: 10.1055/S-0035-1556169  0.724
2014 Chen QY, Liu Y, Cai W, Luesch H. Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity. Journal of Medicinal Chemistry. 57: 3011-29. PMID 24660812 DOI: 10.1021/Jm4019965  0.754
2014 Chen Q, Liu Y, Cai W, Luesch H. Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with enhanced activity Planta Medica. 80. DOI: 10.1055/S-0034-1382377  0.551
Low-probability matches (unlikely to be authored by this person)
2018 Wu F, Zhang S, Xiong A, Gao G, Li W, Cai W, Su C, Chen X, Zhou F, Zhao J, Ren S, Zhou C. A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer. Clinical Lung Cancer. PMID 30026059 DOI: 10.1016/J.Cllc.2018.06.002  0.267
2013 He Y, Li S, Ren S, Cai W, Li X, Zhao C, Li J, Chen X, Gao G, Li W, Zhou F, Zhou C. Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients. Lung Cancer (Amsterdam, Netherlands). 81: 162-6. PMID 23726438 DOI: 10.1016/j.lungcan.2013.05.004  0.223
2015 Cheng N, Li X, Zhao C, Ren S, Chen X, Cai W, Zhao M, Zhang Y, Li J, Wang Q, Zhou C. Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer. Oncology Reports. 33: 833-9. PMID 25482516 DOI: 10.3892/or.2014.3643  0.213
2015 Cheng N, Cai W, Ren S, Li X, Wang Q, Pan H, Zhao M, Li J, Zhang Y, Zhao C, Chen X, Fei K, Zhou C, Hirsch FR. Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer. Oncotarget. PMID 26160838 DOI: 10.18632/oncotarget.4361  0.209
2020 Xie T, Li Y, Ying J, Cai W, Li J, Lee KY, Ricciuti B, Pacheco J, Xing P. Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD). Translational Lung Cancer Research. 9: 2428-2439. PMID 33489804 DOI: 10.21037/tlcr-20-1278  0.189
2014 Zhao M, Zhang Y, Cai W, Li J, Zhou F, Cheng N, Ren R, Zhao C, Li X, Ren S, Zhou C, Hirsch FR. The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer. Cancer. 120: 2299-307. PMID 24737648 DOI: 10.1002/cncr.28725  0.189
2016 Pan H, Jiang T, Cheng N, Wang Q, Ren S, Li X, Zhao C, Zhang L, Cai W, Zhou C. Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancer. Oncotarget. PMID 27409677 DOI: 10.18632/oncotarget.10521  0.185
2017 Jiang T, Cheng R, Zhang G, Su C, Zhao C, Li X, Zhang J, Wu F, Chen X, Gao G, Li W, Cai W, Zhou F, Zhao J, Xiong A, et al. Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study. Clinical Lung Cancer. PMID 28549835 DOI: 10.1016/J.Cllc.2017.04.015  0.183
2010 Cai W, Torreggiani M, Zhu L, Chen X, He JC, Striker GE, Vlassara H. AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease. American Journal of Physiology. Cell Physiology. 298: C624-34. PMID 19955485 DOI: 10.1152/ajpcell.00463.2009  0.18
2018 Zhao M, Zhang Y, Li J, Li X, Cheng N, Wang Q, Cai W, Zhao C, He Y, Chang J, Zhou C. Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC. Oncology Letters. 15: 1089-1096. PMID 29399169 DOI: 10.3892/ol.2017.7411  0.173
2019 Pan D, Zhou D, Cai W, Wu W, Tan WL, Zhou C, Lou Y. Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma. Bmc Immunology. 20: 43. PMID 31722672 DOI: 10.1186/S12865-019-0320-1  0.172
2013 Cai WJ, Su B. [A new target in non-small cell lung cancer: ROS1 fusion gene]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 35: 1-4. PMID 23648291  0.171
2018 Cai W, Zhou D, Wu W, Tan WL, Wang J, Zhou C, Lou Y. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design. Bmc Genomics. 19: 582. PMID 30075702 DOI: 10.1186/S12864-018-4958-5  0.171
2020 Chen H, Liu M, Dai Z, Li S, Luo Y, Wang Y, Su W, Cai W, Yang D, Huang J, Yang Z. Concomitant genetic alterations are associated with response to targeted therapy in patients with lung adenocarcinoma. Translational Lung Cancer Research. 9: 1225-1234. PMID 32953500 DOI: 10.21037/tlcr-20-679  0.171
2006 Cai W, He JC, Zhu L, Lu C, Vlassara H. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proceedings of the National Academy of Sciences of the United States of America. 103: 13801-6. PMID 16954185 DOI: 10.1073/pnas.0600362103  0.168
2015 Cheng N, Cai W, Li X, Wang Q, Zhao M, Li J, Zhao C, Zhou C. HOTAIR to induce EGFR-TKIs resistance in non-small cell lung cancer via epithelial-mesenchymal transition. Journal of Clinical Oncology. 33: e19079-e19079. DOI: 10.1200/jco.2015.33.15_suppl.e19079  0.167
2008 Cai W, He JC, Zhu L, Chen X, Striker GE, Vlassara H. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. American Journal of Physiology. Cell Physiology. 294: C145-52. PMID 18032526 DOI: 10.1152/ajpcell.00350.2007  0.165
2021 Lu G, Cai W, Wang X, Huang B, Zhao Y, Shao Y, Wang D. Identifying prognostic signatures in the microenvironment of prostate cancer. Translational Andrology and Urology. 10: 4206-4218. PMID 34984186 DOI: 10.21037/tau-21-819  0.159
2019 Zhou M, Fan J, Li Z, Li P, Sun Y, Yang Y, Zhou X, Wang J, Wang Y, Qi H, Cai W, Dai X, Hirsch FR. Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer. Respiratory Research. 20: 248. PMID 31699089 DOI: 10.1186/s12931-019-1205-9  0.159
2015 Wang Q, Li X, Ren S, Cheng N, Zhao M, Zhang Y, Li J, Cai W, Zhao C, Cao W, Zhou C. Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer. Plos One. 10: e0122792. PMID 25860145 DOI: 10.1371/journal.pone.0122792  0.157
2008 Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 691-8. PMID 18256374 DOI: 10.2215/CJN.04291007  0.156
2013 Cai W, Su C, Li X, Fan L, Zheng L, Fei K, Zhou C. KIF5B-RET fusions in Chinese patients with non-small cell lung cancer. Cancer. 119: 1486-94. PMID 23378251 DOI: 10.1002/cncr.27940  0.151
2018 Liu S, He Y, Jiang T, Ren S, Zhou F, Zhao C, Li X, Zhang J, Su C, Chen X, Cai W, Gao G, Li W, Wu F, Li J, et al. EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism. Lung Cancer (Amsterdam, Netherlands). 120: 82-87. PMID 29748021 DOI: 10.1016/j.lungcan.2018.04.004  0.144
2016 Cheng N, Wang Q, Cai W, Ren S, Li X, Zhao C, Zhou C. 28PD HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer via epithelial-mesenchymal transition Annals of Oncology. 27. DOI: 10.1093/annonc/mdw574.001  0.142
2018 Ren S, Zhang S, Jiang T, He Y, Ma Z, Cai H, Xu X, Li Y, Cai W, Zhou J, Liu X, Hu X, Zhang J, Yu H, Zhou C, et al. Early detection of lung cancer by using an autoantibody panel in Chinese population. Oncoimmunology. 7: e1384108. PMID 29308305 DOI: 10.1080/2162402X.2017.1384108  0.142
2014 Cheng N, Li X, Ren S, Cai W, Zhou C. 184PLONG NON-CODING RNA UCA1 INDUCES ACQUIRED RESISTANCE OF EGFR-TKIS IN NON-SMALL CELL LUNG CANCER. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv64. PMID 28170642 DOI: 10.1093/annonc/mdu326.18  0.14
2022 Liang L, Li X, Nong L, Cai W, Zhang J, Liu P, Li T. An innovative single-base extension method for synchronous detection of point mutations and MSI status in colorectal cancer. Cancer Medicine. PMID 36583506 DOI: 10.1002/cam4.5557  0.138
2004 Cai W, He JC, Zhu L, Peppa M, Lu C, Uribarri J, Vlassara H. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation. 110: 285-91. PMID 15249511 DOI: 10.1161/01.CIR.0000135587.92455.0D  0.13
2019 Fan J, Dai X, Wang Z, Huang B, Shi H, Luo D, Zhang J, Cai W, Nie X, Hirsch FR. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions. Clinical Lung Cancer. PMID 31138506 DOI: 10.1016/j.cllc.2019.04.008  0.128
2014 Li X, Ren R, Ren S, Chen X, Cai W, Zhou F, Zhang Y, Su C, Zhao C, Li J, Cheng N, Zhao M, Zhou C. Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients. Translational Oncology. 7: 341-8. PMID 25180058 DOI: 10.1016/j.tranon.2014.04.006  0.128
2022 Zhang Z, Xie S, Cai W, Hong ZN, Yang C, Lin Y, Zhu J, Lin Z, Christoph DC, Bohnenberger H, Kepka L, Brueckl WM, Van Houtte P, Kang M, Lin J. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer. Translational Lung Cancer Research. 11: 75-86. PMID 35242629 DOI: 10.21037/tlcr-21-1038  0.128
2020 Cao R, Yang F, Ma SC, Liu L, Zhao Y, Li Y, Wu DH, Wang T, Lu WJ, Cai WJ, Zhu HB, Guo XJ, Lu YW, Kuang JJ, Huan WJ, et al. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer. Theranostics. 10: 11080-11091. PMID 33042271 DOI: 10.7150/thno.49864  0.125
2022 Li Y, Fan L, Zheng J, Nie X, Sun Y, Feng Q, Lian S, Bai W, Cai W, Yang Y, Su B, Xi Y, Lin D. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer. Cancer Biology & Medicine. PMID 35638907 DOI: 10.20892/j.issn.2095-3941.2021.0585  0.124
2016 Wang Q, Cheng N, Li X, Pan H, Li C, Ren S, Su C, Cai W, Zhao C, Zhang L, Zhou C. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget. PMID 27911863 DOI: 10.18632/oncotarget.13708  0.12
2022 Liu X, Wang W, Liu X, Zhang Z, Yu L, Li R, Guo D, Cai W, Quan X, Wu H, Dai M, Liang Z. Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma. Clinical and Translational Medicine. 12: e670. PMID 35061935 DOI: 10.1002/ctm2.670  0.119
2023 Wang H, Zhu Y, Sun W, Yang X, Liu X, Chi K, Huang X, Zhou L, Cai W, Lin D. Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and "the So-Called Reported Histologic Transformation". Cancers. 15. PMID 38067352 DOI: 10.3390/cancers15235649  0.118
2017 Dai Y, Chen A, Liu R, Gu L, Sharma S, Cai W, Salem F, Salant DJ, Pippin JW, Shankland SJ, Moeller MJ, Ghyselinck NB, Ding X, Chuang PY, Lee K, et al. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α. Kidney International. PMID 28756872 DOI: 10.1016/J.Kint.2017.04.026  0.117
2009 Zhao Z, Zhao C, Zhang XH, Zheng F, Cai W, Vlassara H, Ma ZA. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology. 150: 2569-76. PMID 19246537 DOI: 10.1210/en.2008-1342  0.115
2012 Cai W, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proceedings of the National Academy of Sciences of the United States of America. 109: 15888-93. PMID 22908267 DOI: 10.1073/pnas.1205847109  0.113
2007 Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, Koschinsky T, Vlassara H. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care. 30: 2579-82. PMID 17496238 DOI: 10.2337/dc07-0320  0.112
2016 Pereira-Simon S, Rubio GA, Xia X, Cai W, Choi R, Striker GE, Elliot SJ. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice. Plos One. 11: e0159666. PMID 27428057 DOI: 10.1371/journal.pone.0159666  0.111
2014 Cai W, Chen C, Li X, Shi J, Sun Q, Liu D, Sun Y, Hou L, Zhao X, Gu S, Wu Q, Chen H, Zhang W, Jin L, Lu D, et al. Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients. Future Oncology (London, England). 10: 1175-85. PMID 24947259 DOI: 10.2217/Fon.14.25  0.107
2004 Lu C, He JC, Cai W, Liu H, Zhu L, Vlassara H. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 11767-72. PMID 15289604 DOI: 10.1073/pnas.0401588101  0.097
2019 Zhu J, Zhao Y, Liu M, Gonzalez-Rivas D, Xu X, Cai W, Qi H, Dai L, Wang Z, Song X, Jiang G, Yang Y. Developing a New qPCR-Based System for Screening Mutation. Small (Weinheim An Der Bergstrasse, Germany). e1805285. PMID 30677225 DOI: 10.1002/smll.201805285  0.097
2011 Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care. 34: 1610-6. PMID 21709297 DOI: 10.2337/dc11-0091  0.096
2013 Stirban A, Kotsi P, Franke K, Strijowski U, Cai W, Götting C, Tschoepe D. Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins. Diabetes Care. 36: 1278-82. PMID 23238657 DOI: 10.2337/dc12-1489  0.095
2005 Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Annals of the New York Academy of Sciences. 1043: 461-6. PMID 16037267 DOI: 10.1196/annals.1333.052  0.095
2018 Grosjean F, Yubero-Serrano EM, Zheng F, Esposito V, Swamy S, Elliot SJ, Cai W, Vlassara H, Salem F, Striker GE. Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice. Plos One. 13: e0204366. PMID 30252878 DOI: 10.1371/journal.pone.0204366  0.092
2023 Yang J, Zhang B, Guan W, Fan Z, Pu X, Zhao L, Jiang W, Cai W, Quan X, Miao S, Nie L, He L. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes. Cancer Medicine. PMID 36916520 DOI: 10.1002/cam4.5795  0.092
2016 Calvo MS, Mehrotra A, Beelman RB, Nadkarni G, Wang L, Cai W, Boon CG, Kalaras MD, Uribarri J. A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms). Plant Foods For Human Nutrition (Dordrecht, Netherlands). PMID 27193019 DOI: 10.1007/S11130-016-0552-7  0.086
2017 Jiang T, Li X, Wang J, Su C, Han W, Zhao C, Wu F, Gao G, Li W, Chen X, Li J, Zhou F, Zhao J, Cai W, Zhang H, et al. Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC. Theranostics. 7: 4753-4762. PMID 29187901 DOI: 10.7150/Thno.21687  0.086
2006 Cai W, Zhu L, Chen X, Uribarri J, Peppa M. Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients. American Journal of Nephrology. 26: 181-5. PMID 16675897 DOI: 10.1159/000093122  0.084
2017 Li X, Cai W, Yang G, Su C, Ren S, Zhao C, Hu R, Chen X, Gao G, Guo Z, Li W, Zhou C, Hirsch FR. Comprehensive analysis of EGFR-mutant abundance and its effect on efficacy of EGFR-TKIs in advanced NSCLC with EGFR mutations. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28624467 DOI: 10.1016/j.jtho.2017.06.006  0.084
2015 Cai W, Lin D, Wu C, Li X, Zhao C, Zheng L, Chuai S, Fei K, Zhou C, Hirsch FR. Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26416997 DOI: 10.1200/JCO.2014.58.8293  0.083
2014 Uribarri J, Cai W, Pyzik R, Goodman S, Chen X, Zhu L, Ramdas M, Striker GE, Vlassara H. Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases. Amino Acids. 46: 301-9. PMID 23636469 DOI: 10.1007/s00726-013-1502-4  0.081
2001 Zheng F, Cai W, Mitsuhashi T, Vlassara H, Bucala R. Lysozyme Enhances Renal Excretion of Advanced Glycation Endproducts In Vivo and Suppresses Adverse AGE-mediated Cellular Effects In Vitro: A Potential AGE Sequestration Therapy for Diabetic Nephropathy? Molecular Medicine. 7: 737-747. DOI: 10.1007/BF03401963  0.08
2017 Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y, Zhang X, He JC, Zhong Y. Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Scientific Reports. 7: 14603. PMID 29097815 DOI: 10.1038/s41598-017-14906-8  0.079
2012 Jin X, Sun T, Zhao C, Zheng Y, Zhang Y, Cai W, He Q, Taira K, Zhang L, Zhou D. Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA. Nucleic Acids Research. 40: 1797-806. PMID 22039150 DOI: 10.1093/Nar/Gkr927  0.079
2016 Zhou C, Cai W. Intratumoral heterogeneity and EGFR-TKIs resistance Journal of Thoracic Oncology. 11: S15. DOI: 10.1016/J.JTHO.2015.12.025  0.079
2010 Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H. Advanced glycation end products in foods and a practical guide to their reduction in the diet. Journal of the American Dietetic Association. 110: 911-16.e12. PMID 20497781 DOI: 10.1016/j.jada.2010.03.018  0.072
2014 Cai W, Uribarri J, Zhu L, Chen X, Swamy S, Zhao Z, Grosjean F, Simonaro C, Kuchel GA, Schnaider-Beeri M, Woodward M, Striker GE, Vlassara H. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proceedings of the National Academy of Sciences of the United States of America. 111: 4940-5. PMID 24567379 DOI: 10.1073/pnas.1316013111  0.072
2018 Li H, Zhang W, Zhong F, Das GC, Xie Y, Li Z, Cai W, Jiang G, Choi J, Sidani M, Hyink DP, Lee K, Klotman PE, He JC. Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury. Kidney International. PMID 30366682 DOI: 10.1016/J.Kint.2018.07.023  0.071
2015 Uribarri J, Cai W, Woodward M, Tripp E, Goldberg L, Pyzik R, Yee K, Tansman L, Chen X, Mani V, Fayad ZA, Vlassara H. Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? The Journal of Clinical Endocrinology and Metabolism. 100: 1957-66. PMID 25695886 DOI: 10.1210/Jc.2014-3925  0.068
2017 Chuang PY, Cai W, Li X, Fang L, Xu J, Yacoub R, He JC, Lee K. Reduction in podocyte SIRT1 accelerates kidney injury in aging mice. American Journal of Physiology. Renal Physiology. ajprenal.00255.2017. PMID 28615249 DOI: 10.1152/ajprenal.00255.2017  0.068
2009 Torreggiani M, Liu H, Wu J, Zheng F, Cai W, Striker G, Vlassara H. Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. The American Journal of Pathology. 175: 1722-32. PMID 19779136 DOI: 10.2353/ajpath.2009.090138  0.067
2002 Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proceedings of the National Academy of Sciences of the United States of America. 99: 15596-601. PMID 12429856 DOI: 10.1073/pnas.242407999  0.067
1998 Cai W, Yu Y, Young VR, Ajami AM, Tompkins RG. Impact of Burn Injury on γ-Glutainyl Cycle Activity and Glutathione Homeostasis Studied by Stable Isotope Tracer Kinetics Journal of Burn Care & Rehabilitation. 19: S165. DOI: 10.1097/00004630-199801001-00060  0.065
2003 Lin RY, Choudhury RP, Cai W, Lu M, Fallon JT, Fisher EA, Vlassara H. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 168: 213-20. PMID 12801603 DOI: 10.1016/S0021-9150(03)00050-9  0.064
2002 Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Molecular Medicine (Cambridge, Mass.). 8: 337-46. PMID 12393931  0.064
2020 Jin X, Sun T, Zhao C, Zheng Y, Zhang Y, Cai W, He Q, Taira K, Zhang L, Zhou D. Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA. Nucleic Acids Research. PMID 33313865 DOI: 10.1093/nar/gkaa1217  0.062
2012 Vlassara H, Uribarri J, Cai W, Goodman S, Pyzik R, Post J, Grosjean F, Woodward M, Striker GE. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 934-42. PMID 22461535 DOI: 10.2215/CJN.12891211  0.061
2020 Beeri MS, Uribarri J, Cai W, Buchman AS, Haroutunian V. Human Brain and Serum Advanced Glycation End Products are Highly Correlated: Preliminary Results of Their Role in Alzheimer Disease and Type 2 Diabetes. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 26: 576-577. PMID 32396777 DOI: 10.4158/1934-2403-26.5.576  0.06
2015 Illien-Jünger S, Lu Y, Qureshi SA, Hecht AC, Cai W, Vlassara H, Striker GE, Iatridis JC. Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice. Plos One. 10: e0116625. PMID 25668621 DOI: 10.1371/Journal.Pone.0116625  0.059
2020 Gu W, Wang N, Gu W, Qiu Y, Zhang H, Liang J, Zhou T, Ma L, Cai W, Feng W, Chen L. Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma. Translational Lung Cancer Research. 9: 629-638. PMID 32676325 DOI: 10.21037/tlcr-20-457  0.058
2009 Vlassara H, Cai W, Goodman S, Pyzik R, Yong A, Chen X, Zhu L, Neade T, Beeri M, Silverman JM, Ferrucci L, Tansman L, Striker GE, Uribarri J. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. The Journal of Clinical Endocrinology and Metabolism. 94: 4483-91. PMID 19820033 DOI: 10.1210/jc.2009-0089  0.057
2016 Lubitz I, Ricny J, Atrakchi-Baranes D, Shemesh C, Kravitz E, Liraz-Zaltsman S, Maksin-Matveev A, Cooper I, Leibowitz A, Uribarri J, Schmeidler J, Cai W, Kristofikova Z, Ripova D, LeRoith D, et al. High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model. Aging Cell. 15: 309-16. PMID 26781037 DOI: 10.1111/Acel.12436  0.057
2019 Martinez-Saez N, Fernandez-Gomez B, Cai W, Uribarri J, Del Castillo MD. In vitro formation of Maillard reaction products during simulated digestion of meal-resembling systems. Food Research International (Ottawa, Ont.). 118: 72-80. PMID 30898355 DOI: 10.1016/j.foodres.2017.09.056  0.057
2021 Berdún R, Jové M, Sol J, Cai W, He JC, Rodriguez-Mortera R, Martin-Garí M, Pamplona R, Uribarri J, Portero-Otin M. Restriction of Dietary Advanced Glycation end Products Induces a Differential Plasma Metabolome and Lipidome Profile. Molecular Nutrition & Food Research. e2000499. PMID 34599622 DOI: 10.1002/mnfr.202000499  0.054
2011 Beeri MS, Moshier E, Schmeidler J, Godbold J, Uribarri J, Reddy S, Sano M, Grossman HT, Cai W, Vlassara H, Silverman JM. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mechanisms of Ageing and Development. 132: 583-7. PMID 22079406 DOI: 10.1016/J.Mad.2011.10.007  0.051
2014 Schulman CI, Uribarri J, Cai W, Manning R, Landy DC, Gallardo M, Castillo A, Namias N, Striker GE, Livingstone A, Vlassara H. Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 52: 103-8. PMID 23612541 DOI: 10.1515/Cclm-2012-0834  0.051
2003 Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, Croitoru A, Thung S, Vlassara H. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 52: 2805-13. PMID 14578300 DOI: 10.2337/diabetes.52.11.2805  0.051
2010 Mericq V, Piccardo C, Cai W, Chen X, Zhu L, Striker GE, Vlassara H, Uribarri J. Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? Diabetes Care. 33: 2232-7. PMID 20628088 DOI: 10.2337/dc10-1058  0.049
2014 West RK, Moshier E, Lubitz I, Schmeidler J, Godbold J, Cai W, Uribarri J, Vlassara H, Silverman JM, Beeri MS. Dietary advanced glycation end products are associated with decline in memory in young elderly. Mechanisms of Ageing and Development. 140: 10-2. PMID 25037023 DOI: 10.1016/j.mad.2014.07.001  0.048
2004 Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H. Advanced glycoxidation end products in commonly consumed foods. Journal of the American Dietetic Association. 104: 1287-91. PMID 15281050 DOI: 10.1016/j.jada.2004.05.214  0.048
2002 Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes/Metabolism Research and Reviews. 18: 224-37. PMID 12112941 DOI: 10.1002/dmrr.283  0.046
2006 Peppa M, Brem H, Cai W, Zhang JG, Basgen J, Li Z, Vlassara H, Uribarri J. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). American Journal of Nephrology. 26: 430-6. PMID 16974073 DOI: 10.1159/000095786  0.046
2007 Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 62: 427-33. PMID 17452738  0.045
2009 Vlassara H, Uribarri J, Ferrucci L, Cai W, Torreggiani M, Post JB, Zheng F, Striker GE. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Seminars in Nephrology. 29: 594-603. PMID 20006791 DOI: 10.1016/j.semnephrol.2009.07.013  0.045
2016 Villegas-Rodríguez ME, Uribarri J, Solorio-Meza SE, Fajardo-Araujo ME, Cai W, Torres-Graciano S, Rangel-Salazar R, Wrobel K, Garay-Sevilla ME. The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients. Plos One. 11: e0159175. PMID 27434539 DOI: 10.1371/journal.pone.0159175  0.043
2018 Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y, Zhang X, He JC, Zhong Y. Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Scientific Reports. 8: 4294. PMID 29511236 DOI: 10.1038/s41598-018-22371-0  0.043
2017 Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y, Zhang X, He JC, Zhong Y. Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Scientific Reports. 7: 18113. PMID 29273749 DOI: 10.1038/s41598-017-17925-7  0.043
2023 Quan X, Cai W, Xi C, Wang C, Yan L. AIMedGraph: a comprehensive multi-relational knowledge graph for precision medicine. Database : the Journal of Biological Databases and Curation. 2023. PMID 36856726 DOI: 10.1093/database/baad006  0.042
2002 Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes. 51: 2082-9. PMID 12086936 DOI: 10.2337/diabetes.51.7.2082  0.04
2014 Cai W, Li W, Ren S, Zheng L, Li X, Zhou C. Coexistence of three variants involving two different fusion partners of ROS1 including a novel variant of ROS1 fusions in lung adenocarcinoma: a case report. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: e43-6. PMID 24828671 DOI: 10.1097/JTO.0000000000000118  0.039
2020 Lotan R, Ganmore I, Shelly S, Zacharia M, Uribarri J, Beisswenger P, Cai W, Troen AM, Schnaider Beeri M. Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT. Nutrients. 12. PMID 33076217 DOI: 10.3390/nu12103143  0.039
2005 Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes. 54: 2314-9. PMID 16046296  0.039
2008 Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. The American Journal of Pathology. 173: 327-36. PMID 18599606 DOI: 10.2353/ajpath.2008.080152  0.038
2008 Vlassara H, Uribarri J, Cai W, Striker G. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Annals of the New York Academy of Sciences. 1126: 46-52. PMID 18448795 DOI: 10.1196/annals.1433.055  0.038
2007 Cai W, He JC, Zhu L, Chen X, Wallenstein S, Striker GE, Vlassara H. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. The American Journal of Pathology. 170: 1893-902. PMID 17525257 DOI: 10.2353/ajpath.2007.061281  0.038
2021 Lotan R, Ganmore I, Livny A, Shelly S, Zacharia M, Uribarri J, Beisswenger P, Cai W, Schnaider Beeri M, Troen AM. Design and Feasibility of a Randomized Controlled Pilot Trial to Reduce Exposure and Cognitive Risk Associated With Advanced Glycation End Products in Older Adults With Type 2 Diabetes. Frontiers in Nutrition. 8: 614149. PMID 33659267 DOI: 10.3389/fnut.2021.614149  0.035
2004 Peppa M, Uribarri J, Cai W, Lu M, Vlassara H. Glycoxidation and inflammation in renal failure patients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 43: 690-5. PMID 15042546  0.034
2021 Zhou F, Huang Y, Cai W, Li J, Su C, Ren S, Wu C, Zhou C. The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients. Lung Cancer (Amsterdam, Netherlands). 153: 66-72. PMID 33454519 DOI: 10.1016/j.lungcan.2021.01.006  0.031
2017 Yang H, Shi J, Lin D, Li X, Zhao C, Wang Q, Zhang L, Jiang T, Zhao S, Liu X, Jia Y, Zhang Y, Cai W, Zhou C. Prognostic value of PD-L1 expression in combination with CD8(+) TILs density in patients with surgically resected non-small cell lung cancer. Cancer Medicine. PMID 29168339 DOI: 10.1002/cam4.1243  0.03
2003 Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. Journal of the American Society of Nephrology : Jasn. 14: 728-31. PMID 12595509  0.03
2012 Patel R, Baker SS, Liu W, Desai S, Alkhouri R, Kozielski R, Mastrandrea L, Sarfraz A, Cai W, Vlassara H, Patel MS, Baker RD, Zhu L. Effect of dietary advanced glycation end products on mouse liver. Plos One. 7: e35143. PMID 22496902 DOI: 10.1371/Journal.Pone.0035143  0.028
2020 Biruete A, Srinivasan S, O'Neill KD, Vorland CJ, Hill Gallant KM, Cai W, Uribarri J, Johnston N, Allen MR, Chen NX, Moe SM. Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats. American Journal of Nephrology. 1-9. PMID 32146472 DOI: 10.1159/000506729  0.023
2016 Vlassara H, Cai W, Tripp E, Pyzik R, Yee K, Goldberg L, Tansman L, Chen X, Mani V, Fayad ZA, Nadkarni GN, Striker GE, He JC, Uribarri J. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia. PMID 27468708 DOI: 10.1007/S00125-016-4053-X  0.022
2021 Lotan R, Ganmore I, Livny A, Itzhaki N, Waserman M, Shelly S, Zacharia M, Moshier E, Uribarri J, Beisswenger P, Cai W, Troen AM, Beeri MS. Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 34250935 DOI: 10.3233/JAD-210131  0.017
2016 Cai W, Zhou C. Reply to J. Jürgens et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27114595 DOI: 10.1200/JCO.2015.66.3773  0.01
2002 Peppa M, Goldberg T, Cai W, Rayfield E, Vlassara H. Glycotoxins: a missing link in the "relationship of dietary fat and meat intake in relation to risk of type 2 diabetes in men". Diabetes Care. 25: 1898-1899. PMID 12351512  0.01
Hide low-probability matches.